Literature DB >> 2668146

Increased galactose clearance after liver transplantation: a measure of increased blood flow through the denervated liver?

J M Henderson1, W J Millikan, M Hooks, B Noe, M H Kutner, W D Warren.   

Abstract

This study measured the liver blood flow-dependent index of galactose clearance in patients after liver transplantation, to test the hypothesis that liver blood flow is increased in the denervated liver. Eight normal subjects and 16 patients 1 to 8 months after liver transplant were studied. All patients were stable with no evidence of severe rejection at the time of study. Galactose clearance was measured at steady state during continuous infusion of 75 mg per min of 5% galactose. The results show a statistically significant (p less than 0.01) higher average galactose clearance in the transplant patients (1,187 +/- 316 ml per min per m2) compared to the control group (709 +/- 121 ml per min per m2). The major limiting factor in galactose clearance at low concentrations is liver blood flow, and we interpret these data as evidence for increased blood flow in the transplanted liver. Possible mechanisms for the increased galactose clearance are (i) loss of normal vasomotor tone in the denervated liver, or (ii) persistence of abnormal systemic hemodynamics after transplantation. Elucidation of these mechanisms awaits further study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668146     DOI: 10.1002/hep.1840100306

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Indocyanine green elimination test in orthotopic liver recipients.

Authors:  T Tsubono; S Todo; N Jabbour; A Mizoe; V Warty; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

Review 2.  Doppler ultrasonography in living donor liver transplantation recipients: Intra- and post-operative vascular complications.

Authors:  Omar Abdelaziz; Hussein Attia
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

3.  Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation?

Authors:  Roberto Troisi; Guy Cammu; Giuseppe Militerno; Luc De Baerdemaeker; Johan Decruyenaere; Eric Hoste; Peter Smeets; Isabelle Colle; Hans Van Vlierberghe; Mirko Petrovic; Dirk Voet; Eric Mortier; Uwe J Hesse; Bernard de Hemptinne
Journal:  Ann Surg       Date:  2003-03       Impact factor: 12.969

4.  Comparison of liver regeneration between donors and recipients after adult right lobe living-donor liver transplantation.

Authors:  Yuling Zhang; Bei Li; Qing He; Zhiqiang Chu; Qian Ji
Journal:  Quant Imaging Med Surg       Date:  2022-06

5.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.